CPT 81419 Genomic Sequencing Reimbursement

81439-GENOMIC-SEQUENCE-ANALYSIS-PANEL-UTILIZING-FIVE-TO-49-GENES

CPT 81439: Genomic Sequence Analysis Panel for Cardiomyopathy

81430-GENOMIC-SEQUENCE-ANALYSIS-PANEL-EVALUATES-A-PATIENT

CPT 81430: Genomic Sequence Analysis Panel for Hearing Loss and Related Genes

81445-TARGETED-GENOMIC-SEQUENCE-ANALYSIS-PANEL-SOLID-ORGAN

CPT 81445: Targeted Genomic Sequence Analysis Panel for Solid Organ Neoplasms

81441-GENOMIC-SEQUENCE-ANALYSIS-PANEL-SOLID-ORGAN-NEOPLASM-DNA

CPT 81441: Genomic Sequence Analysis Panel for Solid Organ Neoplasms

81451-TARGETED-GENOMIC-SEQUENCE-ANALYSIS-PANEL-HEMATOLYMPHOID

CPT 81451: Targeted Genomic Sequence Analysis Panel, Hematolymphoid RNA (5-50 Genes)

81442-GENOMIC-SEQUENCE-ANALYSIS-PANEL-EVALUATION-OF-AT-LEAST-12

CPT 81442: Genomic Sequence Analysis Panel for Noonan-Spectrum Disorders

81470-TEST-FOR-DETECTING-GENES-ASSOCIATED-WITH-INTELLECTUAL

CPT 81470: Genomic Sequencing for Intellectual Disability Detection

81455-SOLID-ORGAN-OR-HEMATOLYMPHOID-NEOPLASM-OR-DISORDER-51-OR

CPT 81455: Genomic Sequencing Panel for 51+ Gene Neoplasm Analysis

81412-GENOMIC-SEQUENCE-ANALYSIS-PANEL-CARRIER-TESTING-EG

CPT 81412: Genomic Sequence Analysis Panel for Carrier Testing

81450-81450-TARGETED-GENOMIC-SEQUENCE-ANALYSIS-PANEL

CPT 81450: Targeted Genomic Sequence Analysis for Hematolymphoid Neoplasms

OpenPayer